Barclays
GWPH

Barclays’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Barclays’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-37,200
Closed -$4.29M – 5367
2020
Q4 		$4.29M Sell
37,200
-4,000
-10% -$448K ﹤0.01% 1618
2020
Q3 		$4.01M Buy
41,200
+4,000
+11% +$460K ﹤0.01% 1547
2020
Q2 		$4.57M Hold
37,200
– – ﹤0.01% 1449
2020
Q1 		$3.26M Sell
37,200
-15,400
-29% -$1.63M ﹤0.01% 1851
2019
Q4 		$5.5M Hold
52,600
– – ﹤0.01% 1901
2019
Q3 		$6.05M Sell
52,600
-23,000
-30% -$3.49M ﹤0.01% 1682
2019
Q2 		$13M Sell
75,600
-1,000
-1% -$173K 0.01% 1194
2019
Q1 		$12.9M Buy
76,600
+21,400
+39% +$3.18M 0.01% 1077
2018
Q4 		$5.38M Sell
55,200
-31,900
-37% -$4.19M ﹤0.01% 1547
2018
Q3 		$15M Buy
87,100
+2,100
+2% +$303K 0.01% 1009
2018
Q2 		$11.9M Buy
85,000
+84,700
+28,233% +$12M 0.01% 1108
2018
Q1 		$34K Sell
300
-900
-75% -$113K ﹤0.01% 6178
2017
Q4 		$158K Buy
+1,200
New +$141K ﹤0.01% 4892
2017
Q3 		– Sell
-200
Closed -$20K – 7147
2017
Q2 		$20K Sell
200
-10,200
-98% -$1.1M ﹤0.01% 5801
2017
Q1 		$1.26M Sell
10,400
-53,000
-84% -$6.5M ﹤0.01% 2527
2016
Q4 		$7.08M Sell
63,400
-129,100
-67% -$15.5M 0.01% 1154
2016
Q3 		$25.6M Buy
+192,500
New +$18.4M 0.03% 445
2016
Q2 		– Sell
-62,200
Closed -$4.48M – 6761
2016
Q1 		$4.48M Sell
62,200
-418,600
-87% -$23M 0.01% 1265
2015
Q4 		$33.2M Buy
480,800
+464,800
+2,905% +$37.9M 0.04% 389
2015
Q3 		$1.46M Buy
+16,000
New +$1.78M ﹤0.01% 2393

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Barclays's GWPH Position: Q2 2021 in Review

Barclays sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 19,524 shares — an estimated $4.24M sold.

Barclays first reported a position in GWPH in Q4 2013 and held it in 24 quarters. The position peaked at $64.3M in Q4 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Barclays reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Barclays sold 19,524 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4.24M.
  • Barclays first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 24 quarters.
  • Barclays's GW Pharmaceuticals Plc American Depositary Shares position peaked at $64.3M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.